Detalhe da pesquisa
1.
Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(5): 535-552, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142374
2.
Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans.
Nat Biotechnol
; 25(6): 663-8, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17486083
3.
Insight into transcription factor gene duplication from Caenorhabditis elegans Promoterome-driven expression patterns.
BMC Genomics
; 8: 27, 2007 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-17244357
4.
Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing.
Cytometry B Clin Cytom
; 78 Suppl 1: S42-6, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20839337
5.
A compendium of Caenorhabditis elegans regulatory transcription factors: a resource for mapping transcription regulatory networks.
Genome Biol
; 6(13): R110, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16420670